Trial
NCT00411892
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Novo Nordisk A/S
Collaborators
—
Condition
Diabetes
Intervention
pioglitazone
Why stopped
See termination reason in detailed description
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-05